| Financial Year |
March 31 2023 |
| Monetary Funds |
500,489,923.64 |
| Held-for-trading Financial Assets |
60,000,000.00 |
| Notes Receivable |
2,122,686.59 |
| Accounts Receivable |
72,193,177.48 |
| Advances to Suppliers |
10,103,609.70 |
| Other Receivables |
7,689,883.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,007,963.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,305,374.23 |
| Total Current Assets |
675,995,466.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
83,065,599.27 |
| Investment Properties |
-- |
| Fixed Assetes |
102,948,312.99 |
| Under-construction Projects |
4,021,096.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
21,295,314.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
329,294.76 |
| Deferred Income Tax Assets |
576,326.40 |
| Other Non-Current Assets |
5,000,000.00 |
| Sub-Total of Non-Current Assets |
256,161,253.20 |
| Total Assets |
932,156,719.79 |
| Short-Term Loans |
150,418,871.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
8,455,909.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,879,440.41 |
| Taxes Payable |
5,089,817.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,363,463.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
435,978.97 |
| Other Current Liabilities |
342,071.07 |
| Sub-Total of Current Liabilities |
172,616,869.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
744,622.14 |
| Total Liabilities |
173,361,491.14 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
509,501,460.23 |
| Surplus Reserve |
16,090,946.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
144,811,998.54 |
| Minority Stockholder's Interest |
1,785,265.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
757,009,963.12 |
| Owner's Equity（Stockholder's Equity） |
758,795,228.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
932,156,719.79 |
